| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
29,254 |
19,395 |
$3.74M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
57,078 |
48,696 |
$2.40M |
| 64483 |
|
2,351 |
2,214 |
$848K |
| 64493 |
|
1,414 |
1,329 |
$492K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
4,956 |
4,670 |
$416K |
| 62321 |
|
1,368 |
1,303 |
$261K |
| 20610 |
|
2,449 |
2,272 |
$225K |
| G0260 |
Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography |
1,088 |
1,041 |
$182K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
5,537 |
5,332 |
$175K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
580 |
515 |
$87K |
| 62323 |
|
398 |
377 |
$63K |
| 95911 |
|
219 |
211 |
$45K |
| 64635 |
|
61 |
52 |
$29K |
| Q3014 |
Telehealth originating site facility fee |
1,781 |
1,716 |
$27K |
| 64450 |
|
120 |
118 |
$22K |
| 64721 |
|
26 |
26 |
$19K |
| 72100 |
|
1,678 |
1,567 |
$16K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
206 |
206 |
$15K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
58 |
58 |
$12K |
| 72141 |
|
133 |
133 |
$12K |
| 95910 |
|
92 |
88 |
$12K |
| 95816 |
|
68 |
68 |
$10K |
| 20550 |
|
125 |
123 |
$8K |
| 64490 |
|
25 |
24 |
$7K |
| 80305 |
|
1,590 |
1,531 |
$6K |
| 20526 |
|
74 |
73 |
$6K |
| 72110 |
|
208 |
206 |
$4K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
58 |
58 |
$4K |
| 73564 |
|
326 |
284 |
$3K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
16 |
16 |
$3K |
| 22505 |
|
26 |
26 |
$3K |
| 95117 |
|
313 |
109 |
$3K |
| 72050 |
|
180 |
179 |
$3K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
47 |
47 |
$3K |
| 73630 |
|
392 |
315 |
$2K |
| 20600 |
|
29 |
26 |
$2K |
| 64405 |
|
26 |
25 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
104 |
90 |
$2K |
| 95909 |
|
12 |
12 |
$2K |
| 73030 |
|
111 |
111 |
$1K |
| 72040 |
|
148 |
141 |
$1K |
| 73610 |
|
83 |
81 |
$987.78 |
| 73502 |
|
115 |
105 |
$936.89 |
| 72070 |
|
59 |
58 |
$802.20 |
| 99443 |
|
38 |
38 |
$784.44 |
| 20605 |
|
12 |
12 |
$728.64 |
| 73130 |
|
55 |
55 |
$643.98 |
| A4649 |
Surgical supply; miscellaneous |
554 |
477 |
$630.00 |
| 72120 |
|
293 |
292 |
$612.63 |
| 64494 |
|
1,487 |
1,303 |
$572.11 |
| 73110 |
|
26 |
25 |
$359.88 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
91 |
90 |
$322.83 |
| 81002 |
|
198 |
188 |
$215.78 |
| 80047 |
|
203 |
167 |
$103.80 |
| 85027 |
|
176 |
147 |
$74.20 |
| 81025 |
|
539 |
516 |
$70.22 |
| 36415 |
Collection of venous blood by venipuncture |
472 |
419 |
$45.72 |
| 64484 |
|
1,533 |
1,301 |
$32.59 |
| 96127 |
|
93 |
93 |
$20.39 |
| J2704 |
Injection, propofol, 10 mg |
1,060 |
944 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,933 |
1,848 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,992 |
2,709 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
180 |
169 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
593 |
585 |
$0.00 |
| 95886 |
|
600 |
539 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
2,360 |
2,186 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
1,267 |
1,191 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
1,203 |
1,086 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
1,197 |
1,117 |
$0.00 |
| 76377 |
|
126 |
124 |
$0.00 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
32 |
29 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
61 |
56 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15 |
15 |
$0.00 |
| J3490 |
Unclassified drugs |
13 |
12 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13 |
12 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
3,157 |
2,832 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,458 |
2,017 |
$0.00 |
| 64495 |
|
255 |
146 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
52 |
52 |
$0.00 |
| 77003 |
|
224 |
196 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
118 |
110 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
3,162 |
2,928 |
$0.00 |
| 77002 |
|
1,947 |
1,808 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
136 |
136 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
2,398 |
2,192 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
574 |
570 |
$0.00 |
| 72275 |
|
408 |
363 |
$0.00 |
| 64491 |
|
13 |
12 |
$0.00 |
| 93041 |
|
70 |
63 |
$0.00 |
| 64636 |
|
63 |
52 |
$0.00 |
| C1821 |
Interspinous process distraction device (implantable) |
12 |
12 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
15 |
12 |
$0.00 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
19 |
19 |
$0.00 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
12 |
12 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
14 |
14 |
$0.00 |